These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21520112)

  • 21. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
    Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
    Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
    Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
    Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
    Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
    Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.
    Cerutti JM; Delcelo R; Amadei MJ; Nakabashi C; Maciel RM; Peterson B; Shoemaker J; Riggins GJ
    J Clin Invest; 2004 Apr; 113(8):1234-42. PubMed ID: 15085203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
    Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
    Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
    Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
    Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
    Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
    Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
    Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular variant of papillary thyroid carcinoma: comparison of ultrasound-guided core needle biopsy and ultrasound-guided fine needle aspiration in a multicentre study.
    Hahn SY; Shin JH; Lim HK; Jung SL
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):113-119. PubMed ID: 27338864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
    Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
    Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
    Davidov T; Nagar M; Kierson M; Chekmareva M; Chen C; Lu SE; Lin Y; Chernyavsky V; Potdevin L; Arumugam D; Barnard N; Trooskin S
    J Surg Res; 2014 Aug; 190(2):565-74. PubMed ID: 24880201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Chandler JB; Colunga M; Prasad ML; Callender GG; Quinn C; Chhieng D; Adeniran AJ
    Cancer Cytopathol; 2017 Nov; 125(11):865-875. PubMed ID: 28834409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine-Needle Aspiration Cytology of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma Is Cytomorphologically Distinct From the Invasive Counterpart.
    Ibrahim AA; Wu HH
    Am J Clin Pathol; 2016 Sep; 146(3):373-7. PubMed ID: 27543982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.